LakeShore Biopharma Co., Ltd (LSB)
NASDAQ: LSB · Real-Time Price · USD
2.960
+0.260 (9.63%)
At close: Dec 20, 2024, 4:00 PM
3.000
+0.040 (1.35%)
After-hours: Dec 20, 2024, 5:33 PM EST
LakeShore Biopharma Market Cap
LakeShore Biopharma has a market cap or net worth of $56.48 million as of December 20, 2024. Its market cap has increased by 12.52% in one year.
Market Cap
56.48M
Enterprise Value
81.15M
1-Year Change
12.52%
Ranking
Category
Stock Price
2.96
Market Cap Chart
Since August 5, 2021, LakeShore Biopharma's market cap has decreased from $227.76M to $56.48M, a decrease of -75.20%. That is a compound annual growth rate of -33.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 56.48M | 18.77% |
| Dec 29, 2023 | 47.55M | -80.26% |
| Dec 30, 2022 | 240.85M | 3.14% |
| Dec 29, 2021 | 233.52M | 2.53% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SHL Telemedicine | 53.22M |
| Serina Therapeutics | 52.04M |
| MAIA Biotechnology | 52.03M |
| Invivyd | 51.34M |
| Celularity | 51.04M |
| Reviva Pharmaceuticals Holdings | 50.70M |
| AlloVir | 50.64M |
| Singular Genomics Systems | 50.24M |